|
Market Closed -
Sao Paulo
12:16:14 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.790 BRL | -3.93% |
|
+22.42% | -57.94% |
| Market Cap | 158.25Cr 859.3Cr 141.72Cr 130.36Cr 118.12Cr 220.8Cr 15TCr 224.93Cr 1.55TCr 624.07Cr 7.9TCr 593.88Cr 581.25Cr 25TCr | P/E 2026 * |
-4.32x | P/E 2027 * | -28.1x |
|---|---|---|---|---|---|
| Enterprise Value | 115.55Cr 627.47Cr 103.49Cr 95Cr 86Cr 161.23Cr 11TCr 164.25Cr 1.14TCr 455.7Cr 5.77TCr 433.66Cr 424.44Cr 18TCr | EV / Sales 2026 * |
1.52x | EV / Sales 2027 * | 1.05x |
| Free-Float |
96.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ultragenyx Pharmaceutical Inc.
| 1 day | -3.93% | ||
| 1 week | +22.42% | ||
| Current month | +17.67% | ||
| 1 month | +17.67% | ||
| 3 months | -44.92% | ||
| 6 months | -26.32% | ||
| Current year | -57.94% |
| 1 week | 8.58 |  | 9.42 |
| 1 month | 7.07 | | 9.42 |
| Current year | 6.68 | | 18.64 |
| 1 year | 6.68 | | 20.9 |
| 3 years | 6.68 | | 33.03 |
| 5 years | 6.68 | | 39.36 |
| 10 years | 6.68 | | 39.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emil Kakkis
CEO | Chief Executive Officer | 65 | 22/04/2010 |
Howard Horn
DFI | Director of Finance/CFO | 49 | 16/10/2023 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Kakkis
BRD | Director/Board Member | 65 | 22/04/2010 |
Matthew Fust
BRD | Director/Board Member | 62 | 01/01/2014 |
Michael Narachi
BRD | Director/Board Member | 66 | 20/02/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.93% | +22.42% | - | - | 158.25Cr | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,26300Cr | |
| -0.73% | +3.56% | +44.51% | +85.81% | 66TCr | |
| +1.41% | +3.24% | +29.22% | +107.83% | 52TCr | |
| +0.42% | +3.20% | +54.15% | +67.18% | 39TCr | |
| +2.18% | +2.93% | +73.30% | +45.62% | 37TCr | |
| +1.12% | +4.52% | +35.30% | +58.08% | 31TCr | |
| +6.96% | +8.86% | +11.27% | +36.62% | 29TCr | |
| +1.15% | +6.09% | +59.59% | +77.06% | 25TCr | |
| +3.06% | +9.38% | +44.11% | +119.47% | 21TCr | |
| Average | +1.16% | +5.90% | +46.59% | +83.14% | 47.35TCr | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76Cr 412.81Cr 68Cr 63Cr 57Cr 106.07Cr 7.22TCr 108.06Cr 746.84Cr 299.8Cr 3.8TCr 285.3Cr 279.23Cr 12TCr | 100Cr 541.42Cr 89Cr 82Cr 74Cr 139.12Cr 9.47TCr 141.72Cr 979.51Cr 393.21Cr 4.98TCr 374.18Cr 366.23Cr 16TCr |
| Net income | -39Cr -212.04Cr -35Cr -32Cr -29Cr -54Cr -3.71TCr -56Cr -383.62Cr -154Cr -1.95TCr -146.55Cr -143.43Cr -6.15TCr | -7.23Cr -39Cr -6.47Cr -5.95Cr -5.4Cr -10Cr -686.27Cr -10Cr -71Cr -29Cr -361Cr -27Cr -27Cr -1.14TCr |
| Net Debt | -43Cr -231.83Cr -38Cr -35Cr -32Cr -60Cr -4.05TCr -61Cr -419.41Cr -168.37Cr -2.13TCr -160.22Cr -156.81Cr -6.72TCr | -53Cr -288.6Cr -48Cr -44Cr -40Cr -74Cr -5.05TCr -76Cr -522.12Cr -209.6Cr -2.65TCr -199.46Cr -195.21Cr -8.37TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | R$8.790 | -3.93% | 52 |
| 29/26/29 | R$9.150 | -0.87% | 20 |
| 28/26/28 | R$9.230 | +4.41% | 1,531 |
| 27/26/27 | R$8.840 | +1.61% | 124 |
| 26/26/26 | R$8.700 | +21.17% | 420 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RARE Stock
- R2AR34 Stock
Select your edition
All financial news and data tailored to specific country editions
